Register entry
Eirgen Pharma Ltd
- Registered sites
- 1
- Drug products
- 0
- Live patents
- 16
- Countries
- 1
- Base
- Ireland
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackagingRelabellingRepackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Eirgen Pharma Ltd | WaterfordIreland | Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging | 3007075468 |
Exclusivity
Patents
16Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| RAYALDEE | CALCIFEDIOL | Feb 2027 |
| RAYALDEE | CALCIFEDIOL | Apr 2028 |
| RAYALDEE | CALCIFEDIOL | Jul 2028 |
| RAYALDEE | CALCIFEDIOL | Aug 2028 |
| RAYALDEE | CALCIFEDIOL | Sept 2030 |
| RAYALDEE | CALCIFEDIOL | Mar 2034 |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.